Incentive-based Smoking Cessation for Methadone Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Cigarette Smoking Among Patients Currently Receiving Methadone or Buprenorphine Treatment for Opioid Dependence
Interventions
BEHAVIORAL

incentive-based contingency management

Direct comparison of Contingent versus Noncontingent incentives in promoting abstinence from smoking among opioid-treatment patients. The biochemical measures of breath carbon monoxide levels and urinary cotinine are used to confirm smoking status. Participants receive voucher-based incentives either contingent upon demonstrating abstinence from recent smoking (Contingent condition) or independent of smoking status (Noncontingent control condition).

Trial Locations (1)

05401

Substance Abuse Treatment Center, University of Vermont, Burlington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Vermont Medical Center

OTHER

NCT00718835 - Incentive-based Smoking Cessation for Methadone Patients | Biotech Hunter | Biotech Hunter